Oncologists' experience with CGT has increased, with more patients treated and earlier lines of therapy being utilized.

The global cell and gene therapy market is undergoing rapid expansion, driven by the surge in regulatory approvals and continual advancements in therapeutic technologies. The market is anticipated to ...

The move aims to regulate cell and gene therapies, and xenografts or animal-to-human transplants. Such therapies are ...

The Big Pharma’s window to take up exclusive rights to Taysha’s lead asset, dubbed TSHA-102, has officially closed, according ...

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the publication in peer-reviewed journal Nature Medicine of 12-month ...

A longevity gene from supercentenarians restores heart health and slows premature ageing in mice with Hutchinson-Gilford ...

Lexeo Therapeutics Inc. (NASDAQ:LXEO) is one of the best young stocks with huge upside potential. On October 7, Lexeo ...

Centre to amend Drugs Rules related to licensing of stem cell derived & gene therapy products: Gireesh Babu, New Delhi Wednesday, October 22, 2025, 08:00 Hrs [IST] The Union minis ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

The 2022 Option Agreement between Astellas and Taysha has expired Regaining full rights to TSHA-102 Rett syndrome program enables Taysha to focus on driving its long-term value with full strategic fle ...

The first time Joey Carlsen Martinez came to Memorial Sloan Kettering Cancer Center (MSK), he was in terrible shape. He had a ...